Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, health care expenditures, and survival.
Florian KirschChristian BeckerAnja SchrammWerner MaierReiner LeidlPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2020)
Previous and continuous enrollment in the DMP CAD for patients after AMI is a promising strategy as it enhances guideline-recommended medication, reduces health care expenditures and the risk of death.
Keyphrases
- healthcare
- acute myocardial infarction
- health insurance
- end stage renal disease
- ejection fraction
- chronic kidney disease
- coronary artery disease
- percutaneous coronary intervention
- left ventricular
- adverse drug
- peritoneal dialysis
- metabolic syndrome
- acute coronary syndrome
- adipose tissue
- health information
- free survival
- patient reported